Effect of Estimated Plasma Volume Reduction on Renal Function for Acute Heart Failure Differs Between Patients With Preserved and Reduced Ejection Fraction

被引:37
|
作者
Takei, Makoto [1 ]
Kohsaka, Shun [1 ]
Shiraishi, Yasuyuki [1 ]
Goda, Ayumi [3 ]
Izumi, Yuki [4 ]
Yagawa, Mayuko [4 ]
Mizuno, Atsushi [2 ]
Sawano, Mitsuaki [1 ]
Inohara, Taku [1 ]
Kohno, Takashi [1 ]
Fukuda, Keiichi [1 ]
Yoshikawa, Tsutomu [4 ]
机构
[1] Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo 1608582, Japan
[2] St Lukes Int Hosp, Dept Cardiol, Chuo Ku, Tokyo, Japan
[3] Kyorin Univ, Sch Med, Dept Internal Med, Div Cardiol, Mitaka, Tokyo 181, Japan
[4] Sakakibara Heart Inst, Dept Cardiol, Fuchu, Tokyo, Japan
关键词
diuretics; heart failure; diastolic; plasma; BLOOD-VOLUME; HEMOCONCENTRATION; PROGNOSIS; IMPACT;
D O I
10.1161/CIRCHEARTFAILURE.114.001734
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The prognostic relevance of plasma volume reduction (PVR) in acute heart failure patients remains unclear because of the confounding hemodynamic effect of left ventricular ejection fraction impairment on kidney function. Methods and Results Subjects enrolled in the West Tokyo Heart Failure Registry were examined. The PV at admission and discharge was estimated from the subjects' body weight and its deviation from the ideal body weight. Patients in the top tertile of estimated PVR were classified as PVR+. Of the 381 patients with acute heart failure, 181 (47.5%) had heart failure with preserved ejection fraction (HFpEF). Estimated PVR was associated with worsening renal function in the HFpEF (odds ratio, 3.28; 95% confidence interval, 1.55-6.96; P=0.002) but not in the heart failure with reduced ejection fraction cohort (odds ratio, 1.22; 95% confidence interval, 0.61-2.42; P=0.57). This association in the HFpEF cohort remained significant after adjusting for a history of hypertension and diabetes mellitus and the estimated glomerular filtration rate (odds ratio, 3.34; 95% confidence interval, 1.52-7.33; P=0.003). The use of intravenous diuretics was a significant predictor of PVR in the HFpEF and heart failure with reduced ejection fraction groups. Conclusions The effect of estimated PVR differs by HF type, and the estimated PVR during hospitalization is a predictor of worsening renal function in patients with HFpEF but not in heart failure with reduced ejection fraction. Clinical Trial Registration URL: http://www.umin.ac.jp/ctr/index-j.html. Unique identifier: UMIN000001549.
引用
收藏
页码:527 / 532
页数:6
相关论文
共 50 条
  • [21] Acute Decompensated Heart Failure in Patients with Heart Failure with Preserved Ejection Fraction
    Sugimoto, Tadafumi
    HEART FAILURE CLINICS, 2020, 16 (02) : 201 - +
  • [22] Etiology of Heart Failure and Outcomes in Patients Hospitalized for Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction
    Kajimoto, Katsuya
    Minami, Yuichiro
    Sato, Naoki
    Kasanuki, Hiroshi
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (12) : 1881 - 1887
  • [23] Plasma trimethylamine n-oxide is associated with renal function in patients with heart failure with preserved ejection fraction
    Guo, Fei
    Qiu, Xueting
    Tan, Zhirong
    Li, Zhenyu
    Ouyang, Dongsheng
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [24] Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction
    Tromp, Jasper
    Khan, Mohsin A. F.
    Klip, IJsbrand T.
    Meyer, Sven
    de Boer, Rudolf A.
    Jaarsma, Tiny
    Hillege, Hans
    van Veldhuisen, Dirk J.
    van der Meer, Peter
    Voors, Adriaan A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (04):
  • [25] Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction
    Jung, Susanne
    Bosch, Agnes
    Kolwelter, Julie
    Striepe, Kristina
    Kannenkeril, Dennis
    Schuster, Tizia
    Ott, Christian
    Achenbach, Stephan
    Schmieder, Roland E.
    ESC HEART FAILURE, 2021, 8 (02): : 1562 - 1570
  • [26] Reduced Myocardial Flow in Heart Failure Patients With Preserved Ejection Fraction
    Srivaratharajah, Kajenny
    Coutinho, Thais
    deKemp, Robert
    Liu, Peter
    Haddad, Haissam
    Stadnick, Ellamae
    Davies, Ross A.
    Chih, Sharon
    Dwivedi, Girish
    Guo, Ann
    Wells, George A.
    Bernick, Jordan
    Beanlands, Robert
    Mielniczuk, Lisa M.
    CIRCULATION-HEART FAILURE, 2016, 9 (07)
  • [27] Left Ventricular Longitudinal Myocardial Function of Heart Failure Patients With Transition From Reduced to Preserved Ejection Fraction and of Those With Preserved Ejection Fraction
    Nagai, Shun
    Nishimori, Makoto
    Kintsu, Masayuki
    Todo, Saki
    Ota, Eri
    Odajima, Susumu
    Takeuchi, Kimikazu
    Ichikawa, Yasushi
    Yamauchi, Yuki
    Shiraki, Hiroaki
    Yamashita, Kentaro
    Fukuda, Terunobu
    Hisamatsu, Eriko
    Hirata, Ken-ichi
    Tanaka, Hidekazu
    CIRCULATION REPORTS, 2024, 6 (05) : 161 - 167
  • [28] Management of patients with heart failure and preserved ejection fraction
    Jasinska-Piadlo, Alicja
    Campbell, Patricia
    HEART, 2023, 109 (11) : 874 - 883
  • [29] Secondary valve regurgitation in patients with heart failure with preserved ejection fraction, heart failure with mid-range ejection fraction, and heart failure with reduced ejection fraction
    Bartko, Philipp E.
    Hulsmann, Martin
    Hung, Judy
    Pavo, Noemi
    Levine, Robert A.
    Pibarot, Philippe
    Vahanian, Alec
    Stone, Gregg W.
    Goliasch, Georg
    EUROPEAN HEART JOURNAL, 2020, 41 (29) : 2799 - +
  • [30] Discordance between estimated and measured changes in plasma volume among patients with acute heart failure
    Swolinsky, Jutta S.
    Tuvshinbat, Enkhtuvshin
    Leistner, David M.
    Edelmann, Frank
    Knebel, Fabian
    Nerger, Niklas P.
    Lemke, Caroline
    Roehle, Robert
    Haase, Michael
    Costanzo, Maria Rosa
    Rauch, Geraldine
    Mitrovic, Veselin
    Gasanin, Edis
    Meier, Daniel
    McCullough, Peter A.
    Eckardt, Kai-Uwe
    Molitoris, Bruce A.
    Schmidt-Ott, Kai M.
    ESC HEART FAILURE, 2022, 9 (01): : 66 - 76